Employees: 12 (2023.0)Legal category: 5785Size: PMECreation date: 2016-10-24 (9 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: LE PONT-DE-BEAUVOISIN (73330), Savoie
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
GRANDE PHARMACIE DU PONT : revenue, balance sheet and financial ratios
GRANDE PHARMACIE DU PONT is a French company
founded 9 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in LE PONT-DE-BEAUVOISIN (73330),
this company of category PME
shows in 2024 a net income positive of 346 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - GRANDE PHARMACIE DU PONT (SIREN 823338504)
Indicator
2024
2023
2022
2019
2018
2017
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
Net income
346 483 €
303 564 €
404 362 €
370 986 €
333 747 €
104 906 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2024, GRANDE PHARMACIE DU PONT generates positive net income of 346 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2024: 105 k€ -> 346 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
346 483 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 92%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 43%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
91.537%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
42.99%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution GRANDE PHARMACIE DU PONT
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2022
2023
2024
Debt ratio
2161.71
618.375
296.891
111.551
105.716
91.537
Financial autonomy
3.838
12.194
21.878
38.628
39.068
42.99
Repayment capacity
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
91.542024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Average
In 2024, the debt ratio of GRANDE PHARMACIE DU PONT (91.54) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
42.99%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Average
In 2024, the financial autonomy of GRANDE PHARMACIE DU PONT (43.0%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 123.92. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
123.916
Liquidity indicators evolution GRANDE PHARMACIE DU PONT
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2019
2022
2023
2024
Liquidity ratio
158.634
51.867
157.163
118.871
118.932
123.916
Interest coverage
None
None
None
None
None
None
Sector positioning
Liquidity ratio
123.922024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Watch
In 2024, the liquidity ratio of GRANDE PHARMACIE DU PONT (123.92) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Positioning of GRANDE PHARMACIE DU PONT in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of GRANDE PHARMACIE DU PONT is estimated at
4 837 158 €
(range 3 368 520€ - 7 236 666€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
3368k€4837k€7236k€
4 837 158 €Range: 3 368 520€ - 7 236 666€
NAF 5 année 2024
Valuation method used
Net Income Multiple
346 483 €
×
14.0x
=4 837 159 €
Range: 3 368 521€ - 7 236 666€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare GRANDE PHARMACIE DU PONT with other companies in the same sector:
Frequently asked questions about GRANDE PHARMACIE DU PONT
What is the revenue of GRANDE PHARMACIE DU PONT ?
The revenue of GRANDE PHARMACIE DU PONT is not publicly disclosed (confidential accounts filed with INPI).
Is GRANDE PHARMACIE DU PONT profitable?
Yes, GRANDE PHARMACIE DU PONT generated a net profit of 346 k€ in 2024.
Where is the headquarters of GRANDE PHARMACIE DU PONT ?
The headquarters of GRANDE PHARMACIE DU PONT is located in LE PONT-DE-BEAUVOISIN (73330), in the department Savoie.
Where to find the tax return of GRANDE PHARMACIE DU PONT ?
The tax return of GRANDE PHARMACIE DU PONT is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does GRANDE PHARMACIE DU PONT operate?
GRANDE PHARMACIE DU PONT operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart